Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Clinical trial NCT01719003 · COMPLETED
Trial details
- NCT number
- NCT01719003
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-11-01
- Enrollment
- 1413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.